Actinium Pharmaceuticals (ATNM) Other Gross PP&E Adjustments (2021 - 2025)
Actinium Pharmaceuticals (ATNM) has disclosed Other Gross PP&E Adjustments for 6 consecutive years, with -$114000.0 as the latest value for Q4 2025.
- Quarterly Other Gross PP&E Adjustments changed N/A to -$114000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$114000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at -$114000.0 for FY2025, N/A changed from the prior year.
- Other Gross PP&E Adjustments for Q4 2025 was -$114000.0 at Actinium Pharmaceuticals, up from -$1.2 million in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was $773000.0 in Q4 2022, with the low at -$2.6 million in Q2 2023.
- Average Other Gross PP&E Adjustments over 5 years is -$1.0 million, with a median of -$795000.0 recorded in 2021.
- The sharpest move saw Other Gross PP&E Adjustments skyrocketed 197.23% in 2022, then crashed 183700.0% in 2024.
- Over 5 years, Other Gross PP&E Adjustments stood at -$795000.0 in 2021, then surged by 197.23% to $773000.0 in 2022, then tumbled by 339.46% to -$1.9 million in 2023, then increased by 0.7% to -$1.8 million in 2024, then skyrocketed by 93.8% to -$114000.0 in 2025.
- According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at -$114000.0, -$1.2 million, and -$15000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.